Roman researchers achieved an average repigmentation of 75.9 percent in 21 patients with stable vitiligo lesions.
2 Years of Treatment With Dupilumab Led to Improvements In Symptoms of AD and Comorbid Anxiety, Depression
The Cutaneous Connection: A Reminder of Patient Impact
Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Patients With Vitiligo Have Decreased Risk of Subsequent Pulmonary Embolism, Peripheral Vascular Disease
Striving for Melanoma Advancements With the Melanoma Research Alliance